Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

• Status: Completed
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This was a long-term follow-up study of participants who completed Kythera-sponsored trials of ATX-101 (06-03, 07-07, 09-15)

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Kythera Biopharmaceuticals

Criteria

Inclusion Criteria:

• Any subject who successfully completed a Kythera-sponsored clinical trial of ATX-101 (06-03, 07-07, 09-15)

• Signed informed consent

• Willingness to comply with schedule and procedures of the study

Exclusion Criteria:

• Subjects who have had or are undergoing treatment that may affect the evaluation of the submental area will be excluded